THE GLOBAL HEALTH RESEARCH ACCELERATOR CICActive

Company number 12667331Community interest companyIncorporated 2020

Key figures

£100+0.0%
Net assets 2024/25
+0.0%
Average annual growth 2020/21–2024/25
02550751002020/212021/222022/232023/242024/25

Like most small UK companies, THE GLOBAL HEALTH RESEARCH ACCELERATOR CIC does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand242,240422,667216,940690,944620,130
Total assets262,643475,185225,254691,381622,765
Total liabilities262,543475,085225,154691,281622,665
Net assets / total equity100100100100100
Average number of employees33333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: THE GLOBAL HEALTH RESEARCH ACCELERATOR CIC

Company

THE GLOBAL HEALTH RESEARCH ACCELERATOR CIC is a community interest company registered with Companies House under company number 12667331. It was incorporated on 12 Jun 2020. Its status is active. The registered office is in Oxford (OX2). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were £100, up 0% on the previous year. Cash at bank and in hand was £620,130. Total assets were £622,765 and total liabilities £622,665. The company had an average of 3 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 25 Jun 2027.